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TRANS-OBTURATOR MID-URETHRAL SLING IN FEMALE MIXED URINARY 
INCONTINENCE   
 
Hypothesis / aims of study 
Mixed urinary incontinence (MUI) is defined as the complaint of involuntary loss of urine associated with urgency as well as with 
efforts or physical exertion or on sneezing or coughing.  
Some authors have suggested that urethral dysfunction has a central role in MUI. The latest and most fascinating theory on the 
pathogenesis of MUI suggests stress urinary incontinence (SUI) as the origin of the disease: during increased intra-abdominal 
pressure, in the presence of bladder neck incompetence, urine enters the proximal urethra provoking an involuntary detrusor 
contraction through an urethro-detrusorial reflex. Following this theory, mid-urethral slings have been proposed in patients with 
MUI. 
Primary objective of this study was to evaluate, at a mean follow-up of 59 months, the subjective and objective outcomes on 
continence using a trans-obturator mid-urethral sling (TOT) in patients with MUI. Secondary objective was to determine the impact 
on Quality of Life (QoL) as well as which factors potentially influence the success of the procedure. 
 
Study design, materials and methods 
This is a prospective, single-arm, observational study on female patients with MUI and predominant SUI conducted at a high-
volume urogynaecological centre between April 2008 to December 2011. SUI was diagnosed using both the Cough Stress Test 
and urodynamics. All patients had unsuccessfully undergone pelvic floor training and antimuscarinic therapy. The study was 
approved by the ethical committee of the institution. All patients provided informed consent to participate in our study. All patients 
underwent surgical insertion of a trans-obturator mid-urethral sling (Monarc®). Post-operative work-ups were planned for 6 
months, 1 year and then annually. The post-operative assessment was carried out by different authors to those who operated. 
The correction of SUI was evaluated objectively using the standardised Cough Stress Test (CST) and the 1-hour PAD test. The 
subjective cure rates for both SUI and UUI were evaluated using ICIQ-SF and the Patient Global Impression of Improvement 
(PGI-I). The King’s Health questionnaire was used to evaluate Quality of Life (QoL). For the overall results, we defined patients 
as ‘dry’ when they had no urinary leakage and no use of pads; as ‘improved’ with at least a 50% reduction in use of pads and a 
declaration of “satisfaction with the results of the operation”; as ‘failed’ in all other cases. 
Statistical analysis: the McNemar chi-square test, the paired t-test for continuous parametric variables, and the Fisher exact test 
(p<0.05 statistically significant). A logistic regression model and odds ratios (with 95 percent confidence intervals) were used to 
assess the independent prognostic value of six variables for the outcome. A p value of <0.05, using the Chi-square test, was 
considered statistically significant. 
 
Results 
Eighty six consecutive patients with MUI that met all the study criteria were included and evaluated. Mean age was 60 years, 
mean BMI 27.07, median parity 2; 64 patients were post-menopausal. The mean follow-up was 59 months (36-84 months). We 
evaluated the results for SUI and UUI separately. We had an objective cure rate for SUI in 83.7% (72 patients) and a subjective 
cure rate of 81.5% (75 patients). UUI disappeared in 64 patients (74.4%). The overall continence rate (for SUI and UUI together) 
was 62.3% (57 patients). The analysis of urodynamic data showed a statistically significant increase of Detrusor pressure at 
maximum flow (p=0.02) and a significant reduction of Maximum flow (p=0.03) (Table 2). No obstruction, according to Blaivas and 
Groutz nomogram, was observed. Using a univariate analysis, we looked at the performance of 6 variables (age, parity, body 
mass index, menopausal status, pre-op. detrusor overactivity and pre-op PdetQmax ) and we found no significant risk factor for 
failure (Table 3). The King’s Health Questionnaire indicated a statistically significant improvement in QoL in all domains. 
 
Interpretation of results 
In our study transobturator mid-urethral slings correct SUI in 83.7% of the sample, and UUI in 74.4%, with an overall correction 
of incontinence in 62.3%. According to the univariate analysis, we did not find clinical or urodynamic parameter correlated with 
the outcome.  
Our data seem to confirm the theory that, in some patients, MUI could be mainly due to an urethral rather than to a detrusorial 
dysfunction. This hypothesis could be confirmed by the lack of pre-operative response to the antimuscarinic drugs in our sample, 
considering that these drugs act on the detrusorial component of incontinence. 
 
Concluding message 
Our study demonstrates that transobturator mid-urethral slings can be used effectively in patients with MUI with 87.2% of patients 
satisfied of the results of the operation, as confirmed by PGI-I. More studies are needed to identify pre-operative selection criteria 
that could be predictive of the outcome of surgical treatment in patients with MUI. 
 
  
Table 1 – PGI-I values  
Very much better 60 patients (69.8%) 
Much better 15 patients (17.4%) 
A little better 6 patients (6.9%) 
No difference 4 patients (6.9%) 
A little worse 1 patients (1.2%) 
Much worse 0 
Very much worse 0 
Total 86 patients 
 
Table 2- Pre- and post-operatively urodynamic data 
 Pre-op Post-op P 
Cystometric capacity mean 398.2  
(222-593ml) 
mean 370  
(237-520ml) 
0.22§ 
Detrusor overactivity 68 patients (79.1%) 63 patients (73.3%) 0.87* 
PdetQmax mean 16.2  
(1-46 cmH2O) 
mean 25.3  
(9-57 cmH2O) 
0.02§ 
Qmax mean 25.3  
(9-57ml/sec) 
mean 18.4  
(7-28ml/sec) 
0.03§ 
Urodynamic SUI 86 patients (100%) 14 patients (16.3%) 0.0000* 
 
Table 3-  Univariate logistic regression 
Variables Cure rate Failure rate p value* Odds 
ratio 
Age (years) 
   36-59 
   >60 
 
27/57 (47.4%) 
30/57 (52.6%) 
 
10/29 (34.5%) 
19/29 (65.5%) 
0.114 0.474 
Parity 
   0-2 
   3 
 
18/57 (31.6%) 
39/57 (68.4%) 
 
7/29 (70.6%) 
22/29 (29.4%) 
0,547 0.730 
Body mass index  
   21-29 kg/m2 
   >30 kg/m2 
 
40/57 (70.2%) 
17/57 (29.8%) 
 
24/29 (82.8%) 
5/29 (17.2%) 
0.234 2.100 
Menopause 
   yes 
   not 
 
39/57 (68.4%) 
18/57 (31.6%) 
 
25/29(86.2%) 
4/29 (13.8%) 
0.082 0,347 
PdetQmax 
   <20 cmH2l 
   >20 cmH20 
 
49/57 (85.9%) 
8/57 (14.1%) 
 
21/29 (82.4%) 
8/29 (27.6%) 
 
0.876 
 
0.917 
DO 
   yes 
   not 
 
42/57 (73.7%) 
15/57 (26.3%) 
 
26/29 (89.7%) 
3/29 (10.3%) 
0.113 0.338 
*Chi-square test 
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